Show simple item record

dc.contributor.authorSoofiyani, SR
dc.contributor.authorBaradaran, B
dc.contributor.authorLotfipour, F
dc.contributor.authorKazemi, T
dc.contributor.authorMohammadnejad, L
dc.date.accessioned2018-08-26T08:56:07Z
dc.date.available2018-08-26T08:56:07Z
dc.date.issued2013
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/54398
dc.description.abstractGene therapy is one of the most attractive fields in medicine. The concept of gene delivery to tissues for clinical applications has been discussed around half a century, but scientist's ability to manipulate genetic material via recombinant DNA technology made this purpose to reality. Various approaches, such as viral and non-viral vectors and physical methods, have been developed to make gene delivery safer and more efficient. While gene therapy initially conceived as a way to treat life-threatening disorders (inborn errors, cancers) refractory to conventional treatment, to date gene therapy is considered for many non-life-threatening conditions including those adversely influence on a patient's quality of life. Gene therapy has made significant progress, including tangible success, although much slower than was initially predicted. Although, gene therapies still at a fairly primitive stage, it is firmly science based. There is justifiable hope that with enhanced pathobiological understanding and biotechnological improvements, gene therapy will be a standard part of clinical practice within 20 years. é 2013 by Tabriz University of Medical Sciences.
dc.language.isoEnglish
dc.relation.ispartofAdvanced Pharmaceutical Bulletin
dc.subjectadenovirus vector
dc.subjectinterleukin 2 receptor gamma
dc.subjectlentivirus vector
dc.subjectparvovirus vector
dc.subjectretrovirus vector
dc.subjectarticle
dc.subjectclinical trial (topic)
dc.subjectelectroporation
dc.subjectex vivo gene transfer
dc.subjectgene gun immunization
dc.subjectgene therapy
dc.subjectgene vector
dc.subjectgerm line gene therapy
dc.subjecthuman
dc.subjecthydrodynamics
dc.subjectimmune response
dc.subjectin vivo gene transfer
dc.subjectinterleukin 2 receptor gamma gene
dc.subjectnonhuman
dc.subjectnonviral gene delivery system
dc.subjectsevere combined immunodeficiency
dc.subjectsomatic gene therapy
dc.subjectultrasound
dc.subjectviral gene delivery system
dc.subjectviral gene therapy
dc.titleGene therapy, early promises, subsequent problems, and recent breakthroughs
dc.typeArticle
dc.citation.volume3
dc.citation.issue2
dc.citation.spage249
dc.citation.epage255
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.5681/apb.2013.041


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record